Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial - Mitsudomi, T; Morita, S; Yatabe, Y (Lancet Oncol, 2010)
et al.